Literature DB >> 3663474

Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells.

I Nogae1, J Kikuchi, T Yamaguchi, M Nakagawa, N Shiraishi, M Kuwano.   

Abstract

Vitamin A has been shown to potentiate the cytotoxic action of anticancer agents like vincristine (VCR) against drug resistant mouse P388 leukaemia cells. In vitro tests showed enhancement by retinyl acetate of cytocidal activities of VCR against drug-sensitive leukaemia (P388/S) and VCR-resistant leukaemia (P388/VCR) cells in culture; retinyl acetate rather specifically potentiated VCR against cultured P388/VCR cells than P388/S cells. The cellular accumulation of radioactive VCR was significantly enhanced in cultured P388/VCR cells when retinyl acetate was present. The efflux of VCR from drug-resistant cells was blocked by retinyl acetate. The effect of the combination of vitamin A and VCR was also tested in vivo on the life-span of mice bearing P388/S or P388/VCR. Intraperitoneal administration of retinyl palmitate at 41.75 or 83.5 mg kg-1 was effective to potentiate the antileukaemic activity of VCR against P388/S bearing mice, and it also overcame vincristine-resistance in P388/VCR bearing mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3663474      PMCID: PMC2002191          DOI: 10.1038/bjc.1987.188

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  FAT-SOLUBLE VITAMINS AND BIOLOGICAL MEMBRANES.

Authors:  J A LUCY; J T DINGLE
Journal:  Nature       Date:  1964-10-10       Impact factor: 49.962

2.  Augmentation of specific tumor immunity against a syngeneic SV40-induced sarcoma in mice by retinoic acid.

Authors:  M Glaser; R Lotan
Journal:  Cell Immunol       Date:  1979-06       Impact factor: 4.868

3.  Plasma vitamin "A" and carotene levels in squamous cell carcinoma of oral cavity and oro-pharynx.

Authors:  K Ibrahim; N A Jafarey; S J Zuberi
Journal:  Clin Oncol       Date:  1977-06

4.  Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia.

Authors:  M Inaba; R K Johnson
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

5.  Adjuvanticity of vitamin A.

Authors:  D W Dresser
Journal:  Nature       Date:  1968-02-10       Impact factor: 49.962

6.  Vitamin A and the radiation response of experimental tumors: an immune-mediated effect.

Authors:  I F Tannock; H D Suit; N Marshall
Journal:  J Natl Cancer Inst       Date:  1972-03       Impact factor: 13.506

7.  Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A.

Authors:  M H Cohen; P P Carbone
Journal:  J Natl Cancer Inst       Date:  1972-04       Impact factor: 13.506

8.  Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies.

Authors:  J L Biedler; H Riehm
Journal:  Cancer Res       Date:  1970-04       Impact factor: 12.701

9.  Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells.

Authors:  T Skovsgaard
Journal:  Cancer Res       Date:  1978-06       Impact factor: 12.701

10.  Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.

Authors:  M Inaba; H Kobayashi; Y Sakurai; R K Johnson
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

View more
  3 in total

1.  Potentiation of some anticancer agents by dipyridamole against drug-sensitive and drug-resistant cancer cell lines.

Authors:  K Asoh; Y Saburi; S Sato; I Nogae; K Kohno; M Kuwano
Journal:  Jpn J Cancer Res       Date:  1989-05

2.  Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro.

Authors:  A Kiue; T Sano; A Naito; H Inada; K Suzuki; M Okumura; J Kikuchi; S Sato; H Takano; K Kohno
Journal:  Jpn J Cancer Res       Date:  1990-10

3.  Cytotoxic effects of vitamin A in combination with vincristine, daunorubicin and 6-thioguanine upon cells from lymphoblastic leukemic patients.

Authors:  R Pieters; D R Huismans; A H Loonen; K Hählen; A J Veerman
Journal:  Jpn J Cancer Res       Date:  1991-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.